News & Updates
Filter by Specialty:
Add-on cannabidiol induces sustained seizure reduction in treatment-resistant epilepsy
Patients with treatment-resistant epilepsy appear to benefit from add-on cannabidiol, which a recent study has shown to help reduce seizure frequency for up to 192 weeks.
Add-on cannabidiol induces sustained seizure reduction in treatment-resistant epilepsy
27 Jan 2023
Pain, discomfort persist in JIA patients despite medication use
Problems with pain or discomfort continue to bother young adults with juvenile idiopathic arthritis (JIA) despite their constant use of medication, a study has shown.
Pain, discomfort persist in JIA patients despite medication use
18 Jan 2023
Lebrikizumab–topical corticosteroid combo improves outcomes in moderate-to-severe AD
Treatment with lebrikizumab, when combined with low- to mid-potency topical corticosteroid (TCS), helps reduce disease severity in adolescent and adult patients with moderate-to-severe atopic dermatitis (AD), with a safety profile consistent with that reported in previous AD studies, according to the phase III ADhere trial.
Lebrikizumab–topical corticosteroid combo improves outcomes in moderate-to-severe AD
16 Jan 2023
Modified Atkins diet helps control drug-resistant epilepsy
Teen and adult patients with drug-resistant epilepsy may benefit from modified Atkins diet, which has been shown in a recent study to produce improvements in seizure frequency, quality of life (QOL), and behavioural problems as compared with standard drug therapy.
Modified Atkins diet helps control drug-resistant epilepsy
12 Jan 2023
Farm life safeguards children against allergic rhinitis
Growing up on a farm appears to confer a reduced risk of developing allergic rhinitis in children, with the protective effect of farm living being set until school age and sustained through early adulthood.